RNS Number : 2067M Stifel Nicolaus Europe Limited 26 April 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of
RNS Number : 2276M Polar Capital Holdings PLC 26 April 2024 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of
RNS Number : 0845M Renalytix PLC 25 April 2024 Renalytix plc ("Renalytix" or the "Company") Allotment and issue of the Second Tranche Placing Shares Rule 2.9 Announcement LONDON and SALT LAKE CITY - 25 April 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) confirms that the Second
RNS Number : 0095M Stifel Nicolaus Europe Limited 25 April 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name
RNS Number : 8535L Stifel Nicolaus Europe Limited 24 April 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name
RNS Number : 6659L Stifel Nicolaus Europe Limited 23 April 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name
RNS Number : 5771L Renalytix PLC 22 April 2024 Renalytix plc ("Renalytix" or the "Company") Issue of Shares and Rule 2.9 Announcement LONDON and SALT LAKE CITY - 22 April 2024 - Further to the announcements on 8 April 2024 and 15 April 2024 , Renalytix plc (NASDAQ: RNLX) (LSE: RENX)
RNS Number : 5653L Renalytix PLC 22 April 2024 Renalytix plc ("Renalytix" or the "Company") Result of General Meeting LONDON and SALT LAKE CITY , 22 April 2024 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that at the General Meeting (" GM ") held earlier today all resolutions
RNS Number : 4959L Stifel Nicolaus Europe Limited 22 April 2024 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name
